Cristina Paez-Guerrero
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: July 22, 2025
Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 12, 2025
An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation.
Journal: JMIR cancer
Published: February 26, 2025
Different needs ask for different care: Breast cancer patients' preferences regarding assessment of care needs and information provision in personalized aftercare.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: February 07, 2025
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: January 09, 2024
Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
Journal: Preventive medicine
Published: February 02, 2021
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
Journal: Journal of hematology & oncology
Published: January 13, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026